<?xml version="1.0" encoding="utf-8" ?><rss version="2.0"><channel><title>Bing: 2022 Python Video-Tutorials</title><link>http://www.bing.com:80/search?q=2022+Python+Video-Tutorials</link><description>Search results</description><image><url>http://www.bing.com:80/s/a/rsslogo.gif</url><title>2022 Python Video-Tutorials</title><link>http://www.bing.com:80/search?q=2022+Python+Video-Tutorials</link></image><copyright>Copyright © 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><item><title>Truveta unveils platform for the first time at #ViVE2022</title><link>https://www.truveta.com/blog/announcement/vive2022/</link><description>BELLEVUE, Wash.– March 8, 2022 – Truveta, the health system-led company with a vision of saving lives with data, unveiled the Truveta platform in its first public demonstration at #ViVE2022 and shared new insights on COVID-19.</description><pubDate>Wed, 14 Oct 2026 08:42:00 GMT</pubDate></item><item><title>Truveta Studio delivers the health data and analytics</title><link>https://www.truveta.com/blog/announcement/truveta-studio/</link><description>BELLEVUE, Wash. – November 2, 2022 – Today, Truveta announced the availability of Truveta Studio, bringing together unprecedented health data and analytics for researchers to study patient care and outcomes with any condition, drug, or medical device.</description><pubDate>Mon, 02 Nov 2026 10:29:00 GMT</pubDate></item><item><title>Truveta announces collaboration with Boston Scientific</title><link>https://www.truveta.com/blog/announcement/truveta-announces-collaboration-with-boston-scientific/</link><description>BELLEVUE, Wash. – September 27, 2022 –Today, Truveta announced a strategic collaborative agreement with Boston Scientific to improve long-term patient care and gain insights into healthcare disparities.</description><pubDate>Wed, 04 Nov 2026 09:29:00 GMT</pubDate></item><item><title>Truveta announces collaboration with Pfizer | Truveta</title><link>https://www.truveta.com/blog/announcement/truveta-pfizer/</link><description>BELLEVUE, Wash. – June 21, 2022 – Truveta today announced a strategic collaboration with Pfizer to deliver new safety insights on a continuous basis, using verifiable real-world data at scale. Truveta will provide Pfizer with an unprecedented data platform for research.</description><pubDate>Sun, 11 Oct 2026 04:57:00 GMT</pubDate></item><item><title>Truveta earns ISO standards and Type 1 SOC 2 examinations</title><link>https://www.truveta.com/blog/announcement/truveta-advances-security-and-privacy/</link><description>BELLEVUE, Wash.– March 30, 2022 – Truveta, the health system-led company with a vision of saving lives with data, today announced that it has obtained an ISO 27001 certification, with the ISO 27701 and ISO 27018 extensions.</description><pubDate>Thu, 12 Nov 2026 09:27:00 GMT</pubDate></item><item><title>Truveta welcomes four new health system members | Truveta</title><link>https://www.truveta.com/blog/announcement/truveta-welcomes-four-new-health-system-members/</link><description>BELLEVUE, Wash. – September 13, 2022 – Four leading healthcare providers — WellSpan Health, Centura Health, MetroHealth, and Virtua Health — have joined Truveta, the company with a vision of saving lives with data.</description><pubDate>Thu, 22 Oct 2026 02:06:00 GMT</pubDate></item><item><title>New Truveta study shows new trends in syphilis epidemic in US</title><link>https://www.truveta.com/blog/announcement/truveta-study-syphilis-incidence/</link><description>The new study reveals a recent decline in syphilis incidence from its peak in 2022, a trend more pronounced among traditionally higher-burden groups including men, younger adults, those living with HIV, those living in the South, and individuals identifying as Black.</description><pubDate>Wed, 04 Nov 2026 04:28:00 GMT</pubDate></item><item><title>Truveta study in JAMA Network Open on MMR vaccination</title><link>https://www.truveta.com/blog/announcement/new-truveta-research-published-in-jama-network-open-reveals-declining-timeliness-in-childhood-mmr-vaccination-and-identifies-early-predictors-of-missed-immunizations/</link><description>Truveta research in JAMA Network Open finds declining childhood MMR vaccination timeliness and early predictors of missed immunizations.</description><pubDate>Mon, 16 Nov 2026 18:55:00 GMT</pubDate></item><item><title>Tirzepatide 3x More Effective Than Semaglutide | Truveta</title><link>https://www.truveta.com/blog/announcement/mounjaro-three-times-more-effective-than-ozempic-for-weight-loss/</link><description>Using Truveta Data, Truveta Research began with a patient population of over 40,000 patients with overweight or obesity initiating either semaglutide or tirzepatide between May 2022 and September 2023.</description><pubDate>Mon, 16 Nov 2026 03:10:00 GMT</pubDate></item><item><title>Medical Components, Inc. and Truveta advance the use of real-world data</title><link>https://www.truveta.com/blog/announcement/medcomp-truveta/</link><description>Medical Components Inc. and Truveta partner to advance care for patients living with cancer and chronic kidney disease.</description><pubDate>Sat, 10 Oct 2026 13:55:00 GMT</pubDate></item></channel></rss>